Surufatinib plus paclitaxel as second-line therapy for advanced gastric cancer: a single-arm, phase 2 clinical trial. - Han, Ting; Zhuo, Meng; Zheng, Xinyi; Wu, Xiuqi; Jiao, Feng; Cui, Jiujie; Wang, Tao; Qiu, Xiaoxia; Su, Yingjie; Lin, Xiaolin; Xiao, Xiuying (Cellular Oncology (2211-3428), 2025)